These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 10099141)

  • 1. Annexin II and bleeding in acute promyelocytic leukemia.
    Menell JS; Cesarman GM; Jacovina AT; McLaughlin MA; Lev EA; Hajjar KA
    N Engl J Med; 1999 Apr; 340(13):994-1004. PubMed ID: 10099141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic trioxide, retinoic acid and Ara-c regulated the expression of annexin II on the surface of APL cells, a novel co-receptor for plasminogen/tissue plasminogen activator.
    Zhang X; Zhou H; Wang J; Yang L; Hu Y; Shen G; Guo P; Qiao Z; Song S
    Thromb Res; 2002 Apr; 106(1):63-70. PubMed ID: 12165291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia.
    Liu Y; Wang Z; Jiang M; Dai L; Zhang W; Wu D; Ruan C
    Leuk Res; 2011 Jul; 35(7):879-84. PubMed ID: 21146216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study on the fibrinolytic activity in patients with acute promyelocytic leukemia].
    Liu YH; Wang ZY; Zhang W; Dai L; Shen WH; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2009 Mar; 30(3):145-9. PubMed ID: 19642359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annexin A2-S100A10 heterotetramer is upregulated by PML/RARα fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia.
    Huang D; Yang Y; Sun J; Dong X; Wang J; Liu H; Lu C; Chen X; Shao J; Yan J
    Front Med; 2017 Sep; 11(3):410-422. PubMed ID: 28687976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of S100A10 by the PML-RAR-α oncoprotein.
    O'Connell PA; Madureira PA; Berman JN; Liwski RS; Waisman DM
    Blood; 2011 Apr; 117(15):4095-105. PubMed ID: 21310922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin II cell surface and mRNA expression in human acute myeloid leukaemia cell lines.
    Olwill SA; McGlynn H; Gilmore WS; Alexander HD
    Thromb Res; 2005; 115(1-2):109-14. PubMed ID: 15567461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia.
    De Stefano V; Teofili L; Sica S; Mastrangelo S; Di Mario A; Rutella S; Salutari P; Rumi C; d'Onofrio G; Leone G
    Blood; 1995 Nov; 86(9):3535-41. PubMed ID: 7579461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferons and retinoids enhance and dexamethasone suppresses urokinase-mediated plasminogen activation in promyelocytic leukemia cells.
    Mustjoki S; Tapiovaara H; Sirén V; Vaheri A
    Leukemia; 1998 Feb; 12(2):164-74. PubMed ID: 9519778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annexin II: a plasminogen-plasminogen activator co-receptor.
    Kim J; Hajjar KA
    Front Biosci; 2002 Feb; 7():d341-8. PubMed ID: 11815288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The fibrinolytic activity in leukemic cell lines and its alteration on all-trans retinoic acid treatment].
    Xie Y; Wang ZY; Zhang W; Dai L; Bai X
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):588-92. PubMed ID: 17278423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans retinoic acid-induced downregulation of annexin II expression in myeloid leukaemia cell lines is not confined to acute promyelocytic leukaemia.
    Olwill SA; McGlynn H; Gilmore WS; Alexander HD
    Br J Haematol; 2005 Oct; 131(2):258-64. PubMed ID: 16197459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coagulopathy of acute promyelocytic leukaemia revisited.
    Stein E; McMahon B; Kwaan H; Altman JK; Frankfurt O; Tallman MS
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):153-63. PubMed ID: 19285282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemostatic problems in acute promyelocytic leukaemia.
    Arbuthnot C; Wilde JT
    Blood Rev; 2006 Nov; 20(6):289-97. PubMed ID: 16757074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia.
    Jácomo RH; Santana-Lemos BA; Lima AS; Assis PA; Lange AP; Figueiredo-Pontes LL; Oliveira LO; Bassi SC; Benício MT; Baggio MS; Garcia AB; Falcão RP; Rego EM
    Blood; 2012 Jul; 120(1):207-13. PubMed ID: 22517898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide downregulates the expression of annexin II in bone marrow cells from patients with acute myelogenous leukemia.
    Zhang XH; Hu Y; Bao L; Jiang Q; Yang LH; Lu XJ; Hong M; Xia LH; Guo T; Shen GX; Zhu HH; Zhao T; Song SJ
    Chin Med J (Engl); 2009 Sep; 122(17):1969-73. PubMed ID: 19781379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and modulation of annexin VIII in human leukemia-lymphoma cell lines.
    Hu ZB; Ma W; Uphoff CC; Drexler HG
    Leuk Res; 1993 Nov; 17(11):949-57. PubMed ID: 8231235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
    Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
    Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.
    Dombret H; Scrobohaci ML; Daniel MT; Micléa JM; Castaigne S; Chomienne C; Fenaux P; Degos L
    Leukemia; 1995 Jan; 9(1):19-24. PubMed ID: 7531260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.